Data, Statistics, and Clinical Trial Support Center (DSC6)

The National Institute on Drug Abuse (NIDA) invites you to submit a proposal responding to the requirements of this RFP No. 75N95022R00009 for the Clinical Trial Networks (CTN) Data, Statistics, and Clinical Trial Support Center (DSC6). This Request for Proposal is released under FULL AND OPEN Competition Procedures. NIDA prepared this Request for Proposal (RFP) in accordance with the Uniform Contract Format prescribed for Government Wide application by the Federal Acquisition Regulation (FAR). The Uniform Contract Format is both a RFP and a contract award document. The resulting contract will consist of Parts I, II, and III of the Uniform Contract Format. NIDA anticipates that one (1) indefinite delivery, indefinite quantity (IDIQ), task order contract will be awarded for a period of performance of five (5) years. NIDA intends to award cost reimbursement task orders under this contract. These individual task orders may include options periods and/or options quantities. If options are utilized for an individual task order they will be clearly defined in the Task Order RFP and be determined and evaluated at the time of task order solicitation and award. Options for Increased Quantity will be priced and evaluated prior to award and shall be established at the contract level. All funding will be made through the issuance of task orders and will be dependent on program needs and availability of funds. Various task orders will be issued to support distinct tasks and studies which will separately support the CTN and the National Institutes of Health (NIH) launched HEAL (Helping to End Addiction Long-term) Initiative. Proposals must be submitted via the electronic Contract Proposal Submission (eCPS) website (https://ecps.nih.gov) no later than February 15th, 2022, 3:00 P.M. Eastern Time. Proposals submitted by facsimile, email, or hard copy will not be accepted. An official authorized to bind your organization must sign the proposal. Offerors are solely responsible for submitting proposals in a timely manner. Please note that creating an account to submit may take up to three (3) business days. Please plan accordingly. Additional instructions on submitting a proposal via eCPS can be found at https://ecps.nih.gov/home/howto and in Attachment 1. All notices related to this solicitation will be posted on www.SAM.gov (https://www.sam.gov) as well as the NIDA Contracts Home Page (https://www.drugabuse.gov/funding/funding-opportunities/nida-requests-contractproposals-rfps). If you would like to receive e-mail notifications of updates to this solicitation, please register with SAM. In accordance with FAR 15.306(a)(3) and FAR 52.215-1, the Government intends to evaluate proposals and award a contract without discussions. Therefore, your initial proposal should contain the best terms from cost or price and technical standpoints. The Government does, however, reserve the right to conduct discussions if the Contracting Officer determines them to be necessary. Disclaimers. This RFP does not commit the Government to pay the costs for the preparation and submission of a proposal. The Contracting Officer is the only individual who legally can commit the Government to the expenditure of public funds in connection with this acquisition. Any contract award for this requirement is contingent on the availability of funds (see FAR 52.232-18, Availability of Funds - April 1984). Please refer to the attached RFP document for specifications and details. PLEASE NOTE THIS SOLICITATION HAS BEEN AMENDED. The purpose of Amendment No. 01 is to respond to formal questions submitted in response to the Request for Proposals. Please see the Attachment RFP_75N95022R00009_Amendment 01 for details. PLEASE NOTE THIS SOLICITATION HAS BEEN AMENDED. The purpose of Amendment No. 02 is to provide additional clarification to formal questions submitted in response to the solicitation. This amendment shall also extend the solicitation due date to February 15, 2022 at 03:00 pm EST. Please see the Attachment RFP_75N95022R00009_Amendment 02 for details.